CAG
NVO

Csenge Advisory Group’s Novo Nordisk NVO Stock Holding History

Csenge Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,778
Closed -$699K – 745
2025
Q2 		$699K Sell
9,778
-278
-3% -$18.9K 0.04% 342
2025
Q1 		$584K Sell
10,056
-402
-4% -$33.2K 0.03% 363
2024
Q4 		$900K Sell
10,458
-17,649
-63% -$1.91M 0.05% 285
2024
Q3 		$3.37M Buy
28,107
+585
+2% +$78K 0.18% 103
2024
Q2 		$3.93M Buy
27,522
+4,254
+18% +$564K 0.22% 88
2024
Q1 		$2.99M Buy
23,268
+3,694
+19% +$440K 0.17% 111
2023
Q4 		$2.02M Buy
19,574
+9,817
+101% +$971K 0.13% 135
2023
Q3 		$887K Buy
9,757
+3,159
+48% +$278K 0.06% 231
2023
Q2 		$534K Buy
6,598
+2,462
+60% +$201K 0.04% 351
2023
Q1 		$329K Sell
4,136
-322
-7% -$22.8K 0.02% 446
2022
Q4 		$302K Sell
4,458
-626
-12% -$36.7K 0.02% 461
2022
Q3 		$253K Buy
5,084
+190
+4% +$10.2K 0.02% 508
2022
Q2 		$273K Sell
4,894
-38
-0.8% -$2.11K 0.02% 469
2022
Q1 		$274K Buy
4,932
+118
+2% +$6.06K 0.02% 517
2021
Q4 		$203K Sell
4,814
-326
-6% -$17.7K 0.02% 533
2021
Q3 		$246K Buy
5,140
+326
+7% +$15.8K 0.02% 509
2021
Q2 		$203K Buy
+4,814
New +$187K 0.02% 536
2018
Q4 		– Sell
-86
Closed -$1K – 1055
2018
Q3 		$1K Buy
+86
New +$2.1K ﹤0.01% 898

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Csenge Advisory Group's NVO Position: Q3 2025 in Review

Csenge Advisory Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 9,778 shares — an estimated $699K sold.

Csenge Advisory Group first reported a position in NVO in Q3 2018 and held it in 18 quarters. The position peaked at $3.93M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Csenge Advisory Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Csenge Advisory Group sold 9,778 Novo Nordisk shares in Q3 2025, an estimated $699K.
  • Csenge Advisory Group first reported a position in Novo Nordisk in Q3 2018 and held it in 18 quarters.
  • Csenge Advisory Group's Novo Nordisk position peaked at $3.93M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Csenge Advisory Group's 13F filing for Q3 2025, filed 28 Oct 2025.